Regulation of glial cell functions by PPAR-γ natural and synthetic agonists

PPAR Research

Volumn , Issue , 2008, Pages

  Bernardo, Antonietta ^a   Minghetti, Luisa ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 [1 CARBOXY 2 [4 [2 (5 METHYL 2 PHENYL 4 OXAZOLYL)ETHOXY]PHENYL]ETHYLAMINO]BENZOIC ACID METHYL ESTER; 2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; 2 CHLORO 5 NITROBENZANILIDE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CIGLITAZONE; DICLOFENAC; FARGLITAZAR; FLURBIPROFEN; FLURBIPROFEN 4 NITROXYBUTYL ESTER; GAMMA INTERFERON; IBUPROFEN; INDOMETACIN; LONG CHAIN FATTY ACID; N (2 BENZOYLPHENYL) O [2 (METHYL 2 PYRIDINYLAMINO)ETHYL]TYROSINE; NONSTEROID ANTIINFLAMMATORY AGENT; NXC 2216; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ASTROCYTE; BRAIN DAMAGE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; DRUG MECHANISM; DRUG RESEARCH; GLIA CELL; HUMAN; INFLAMMATION; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW;

EID: 44049097234     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/864140     Document Type: Review

References (94)

1. Desvergne B., Wahli W., Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocrine Reviews 1999 20 5 649 688
2. Escher P., Wahli W.
3. Stumvoll M., Stefan N., Fritsche A., Interaction effect between common polymorphisms in PPAR γ 2 (Pro12Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity Journal of Molecular Medicine 2002 80 1 33 38
4. Willson T. M., Lambert M. H., Kliewer S. A., Peroxisome proliferator-activated receptor γ and metabolic disease Annual Review of Biochemistry 2001 70 341 367
5. Heneka M. T., Landreth G. E., Hüll M., Drug Insight: effects mediated by peroxisome proliferator-activated receptor- γ in CNS disorders Nature Clinical Practice Neurology 2007 3 9 496 504
6. Pedersen W. A.
7. Watson G. S., Cholerton B. A., Reger M. A., Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study American Journal of Geriatric Psychiatry 2005 13 11 950 958
8. Jiang Q., Heneka M. T., Landreth G. E.
9. Breidert T.
10. Schütz B., Reimann J., Dumitrescu-Ozimek L., The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice Journal of Neuroscience 2005 25 34 7805 7812
11. Shimazu T., Inoue I., Araki N., A peroxisome proliferator-activated receptor- γ agonist reduces infarct size in transient but not in permanent ischemia Stroke 2005 36 2 353 359
12. Sundararajan S.
13. Tureyen K., Kapadia R., Bowen K. K., Peroxisome proliferator-activated receptor- γ agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents Journal of Neurochemistry 2007 101 1 41 56
14. Zhao X., Zhang Y., Strong R., Grotta J. C., Aronowski J., 15d-prostaglandin J 2 activates peroxisome proliferator-activated receptor- γ, promotes expression of catalase, and reduces inflammation, behavioural dysfunction, and neuronal loss after intracerebral haemorrhage in rats Journal of Cerebral Blood Flow & Metabolism 2006 26 6 811 820
15. Blanco M., Moro M. A., Dávalos A., Increased plasma levels of 15-deoxy à prostaglandin J 2 are associated with good outcome in acute atherothrombotic ischemic stroke Stroke 2005 36 6 1189 1194
16. Park S.-W., Yi J.-H., Miranpuri G., Thiazolidinedione class of peroxisome proliferator-activated receptor γ agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats Journal of Pharmacology and Experimental Therapeutics 2007 320 3 1002 1012
17. Lovett-Racke A. E., Hussain R. Z., Northrop S., Peroxisome proliferator-activated receptor α agonists as therapy for autoimmune disease Journal of Immunology 2004 172 9 5790 5798
18. Polak P. E., Kalinin S., Dello Russo C., Protective effects of a peroxisome proliferator-activated receptor- β/δ agonist in experimental autoimmune encephalomyelitis Journal of Neuroimmunology 2005 168 1-2 65 75
19. Niino M., Iwabuchi K., Kikuchi S., Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor- γ Journal of Neuroimmunology 2001 116 1 40 48
20. Natarajan C., Bright J. J., Peroxisome proliferator-activated receptor- γ agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signalling and Th1 differentiation Genes & Immunity 2002 3 2 59 70
21. Diab A., Deng C., Smith J. D., Peroxisome proliferator-activated receptor- γ agonist 15-deoxy- à 12,14 -prostaglandin J 2 ameliorates experimental autoimmune encephalomyelitis Journal of Immunology 2002 168 5 2508 2515
22. Feinstein D. L.
23. Raikwar H. P., Muthian G., Rajasingh J., Johnson C. N., Bright J. J.
24. Dasgupta S., Roy A., Jana M., Hartley D. M., Pahan K.
25. Peiris M.
26. Malchiodi-Albedi F., Matteucci A., Bernardo A., Minghetti L., PPAR- γ, microglial cells and ocular inflammation: new venues for potential therapeutic approaches PPAR Research 2008 2008 12
27. Pershadsingh H. A.
28. Ricote M.
29. Feinstein D. L.
30. Mukherjee R.
31. Fajas L., Auboeuf D., Raspé E., The organisation, promoter analysis, and expression of the human PPAR γ gene Journal of Biological Chemistry 1997 272 30 18779 18789
32. Fajas L., Fruchart J.-C., Auwerx J.
33. Kliewer S. A., Lenhard J. M., Willson T. M., Patel I., Morris D. C., Lehmann J. M., A prostaglandin J 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation Cell 1995 83 5 813 819
34. Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M., Evans R. M., 15-deoxy- à 12,14 -prostaglandin J 2 is a ligand for the adipocyte determination factor PPAR γ Cell 1995 83 5 803 812
35. Bernando A., Minghetti L.
36. Bernardo A., Ajmone-Cat M. A., Gasparini L., Ongini E., Minghetti L.
37. Bernardo A., Gasparini L., Ongini E., Minghetti L.
38. Trotter J., The development of myelin-forming glia: studies with primary cell cultures and immortalized cell lines Perspectives on Developmental Neurobiology 1993 1 3 149 154
39. Back S. A., Luo N. L., Borenstein N. S., Levine J. M., Volpe J. J., Kinney H. C., Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury Journal of Neuroscience 2001 21 4 1302 1312
40. Back S. A.
41. Bernardo A., Greco A., Levi G., Minghetti L.
42. Zawadzka M., Franklin R. J. M.
43. Granneman J. G., Skoff R.
44. Saluja I., Granneman J. G., Skoff R. P.
45. Roth A. D., Leisewitz A. V., Jung J. E., PPAR γ activators induce growth arrest and process extension in B12 oligodendrocyte-like cells and terminal differentiation of cultured oligodendrocytes Journal of Neuroscience Research 2003 72 4 425 435
46. Kassmann C. M., Lappe-Siefke C., Baes M., Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes Nature Genetics 2007 39 8 969 976
47. Calamandrei G.
48. Piscopo P., Bernardo A., Calamandrei G., Altered expression of cyclooxygenase-2, presenilins and oxygen radical scavenging enzymes in a rat model of global perinatal asphyxia Experimental Neurology 2008 209 1 192 198
49. Xiang Z.
50. Bernardo A., Ajmone-Cat M. A., Levi G., Minghetti L.
51. Nedergaard M., Dirnagl U.
52. Farina C.
53. Cullingford T. E., Bhakoo K., Peuchen S., Dolphin C. T., Patel R., Clark J. B., Distribution of mRNAs encoding the peroxisome proliferator-activated receptor α, β, and γ and the retinoid X receptor α, β, and γ in rat central nervous system Journal of Neurochemistry 1998 70 4 1366 1375
54. Cristiano L., Bernardo A., Cerù M. P.
55. Dello Russo C.
56. Romera C., Hurtado O.
57. Toyomoto M., Ohta M., Okumura K., Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures FEBS Letters 2004 562 1-3 211 215
58. Luna-Medina R., Cortes-Canteli M., Alonso M., Santos A., Martínez A., Perez-Castillo A.
59. Luna-Medina R., Cortes-Canteli M., Sanchez-Galiano S., NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders Journal of Neuroscience 2007 27 21 5766 5776
60. Janabi N., Selective inhibition of cyclooxygenase-2 expression by 15-deoxy- à 12,14 -prostaglandin J 2 in activated human astrocytes, but not in human brain macrophages Journal of Immunology 2002 168 9 4747 4755
61. Lennon A. M., Ramaugé M., Dessouroux A., Pierre M., MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy- à 12,14 -prostaglandin J 2 and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor γ -independent mechanisms involving reactive oxygenated species Journal of Biological Chemistry 2002 277 33 29681 29685
62. Park E. J., Park S. Y., Joe E.-H., Jou I.
63. Xu J., Drew P. D.
64. Storer P. D., Xu J., Chavis J., Drew P. D.
65. Paintlia A. S., Paintlia M. K., Singh I., Singh A. K.
66. Kitamura Y., Taniguchi T., Kimura H., Nomura Y., Gebicke-Haerter P. J.
67. Loane D. J., Deighan B. F., Clarke R. M., Griffin R. J., Lynch A. M., Lynch M. A., Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain. Neurobiology of Aging. In press
68. Phulwani N. K., Feinstein D. L., Gavrilyuk V., Akar C., Kielian T.
69. Zurich M.-G.
70. Kreutzberg G. W., Microglia: a sensor for pathological events in the CNS Trends in Neurosciences 1996 19 8 312 318
71. Nimmerjahn A., Kirchhoff F., Helmchen F.
72. Perry V. H.
73. Kielian T., Drew P. D.
74. Petrova T. V., Akama K. T., Van Eldik L. J.
75. Koppal T., Petrova T. V., Van Eldik L. J.
76. Bernardo A., Levi G., Minghetti L.
77. Drew P. D.
78. Kielian T.
79. Kim E. J., Kwon K. J., Park J.-Y., Lee S. H., Moon C.-H., Baik E. J., Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2 Brain Research 2002 941 1-2 1 10
80. Combs C. K., Johnson D. E., Karlo J. C., Cannady S. B., Landreth G. E.
81. Gasparini L., Ongini E.
82. Jantzen P. T., Connor K. E., DiCarlo G., Microglial activation and β -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice Journal of Neuroscience 2002 22 6 2246 2254
83. Straus D. S., Pascual G., Li M., 15-deoxy- à 12,14 -prostaglandin J 2 inhibits multiple steps in the NF- κ B signaling pathway Proceedings of the National Academy of Sciences of the United States of America 2000 97 9 4844 4849
84. Kennedy T. A., Smith C. J., Marnett L. J., Investigation of the role of cysteines in catalysis by prostaglandin endoperoxide synthase Journal of Biological Chemistry 1994 269 44 27357 27364
85. Maxey K. M.
86. Shibata T., Yamada T., Kondo M., An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy- à 12,14 -prostaglandin J 2 on proteasome Biochemistry 2003 42 47 13960 13968
87. Hortelano S., Castrillo A., Alvarez A. M., Bosca L., Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages Journal of Immunology 2000 165 11 6525 6531
88. Harris S. G., Padilla J., Koumas L., Ray D., Phipps R. P.
89. Kondo M., Shibata T., Kumagai T., 15-deoxy- à 12,14 -prostaglandin J 2: the endogenous electrophile that induces neuronal apoptosis Proceedings of the National Academy of Sciences of the United States of America 2002 99 11 7367 7372
90. Zander T., Kraus J. A., Grommes C., Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPAR γ Journal of Neurochemistry 2002 81 5 1052 1060
91. Harris S. G., Phipps R. P., The nuclear receptor PPAR γ is expressed by mouse T lymphocytes and PPAR γ agonists induce apoptosis European Journal of Immunology 2001 31 4 1098 1105
92. Risner M. E., Saunders A. M., Altman J. F. B., Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease The Pharmacogenomics Journal 2006 6 4 246 254
93. Lee J., Reding M.
94. Dormandy J. A., Charbonnel B., Eckland D. J. A., Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial The Lancet 2005 366 9493 1279 1289